Q2 2025 Teleflex Inc Earnings Call Transcript
Key Points
- Teleflex Inc (TFX) reported second-quarter revenues of $780.9 million, exceeding the high end of their guidance range.
- The acquisition of the Vascular Intervention business from BIOTRONIK is expected to drive sustainable revenue growth and improve margins.
- The company achieved a 9.1% increase in adjusted earnings per share year over year, reaching $3.73.
- Teleflex Inc (TFX) is actively pursuing strategic initiatives, including the potential sale or spin-off of NewCo, to maximize shareholder value.
- The company reported strong performance in its Interventional business, with a 19.3% year-over-year revenue increase, driven by products like intra-aortic balloon pumps and catheters.
- EMEA revenues decreased by 2.1% year over year, which was softer than expected.
- The Anesthesia business saw a revenue decrease of 7.6% year over year, impacted by tough year-over-year comparisons in military orders.
- Interventional Urology revenue decreased by 8.3% year over year, with continued pressure on UroLift.
- OEM revenue decreased by 12.4% year over year due to a lost customer contract and customer inventory management.
- Adjusted gross margin decreased by 110 basis points year over year, primarily due to cost inflation and unfavorable product mix.
Please standby. Good morning, ladies and gentlemen, and welcome to the Teleflex second-quarter 2025 earnings conference call. (Operator Instructions) Please note that this conference call is being recorded and will be available on the company's website for replay shortly.
And now I will turn the call over to Mr. Lawrence Keusch, Vice President of Investor Relations and Strategy Development.
Good morning, everyone, and welcome to the Teleflex Inc. second-quarter 2025 earnings conference call. The press release and slides to accompany this call are available on our website at teleflex.com. As a reminder, a replay will be available on our website. Those wishing to access the replay can refer to our press release from this morning for details.
Participating on today's call are Liam Kelly, Chairman, President and Chief Executive Officer; and John Deren, Executive Vice President and Chief Financial Officer. Liam and John will provide prepared remarks and then we will open the call to Q&A.
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
